The neurobiology of motivational deficits in depression—an update on candidate pathomechanisms

Current Topics in Behavioral Neurosciences

Volumn 27, Issue , 2016, Pages 337-355

  Treadway, Michael T ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Depression; Dopamine; Effort based decision making; Inflammation; Motivation; Neuroplasticity; Reinforcement learning

Indexed keywords

AMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; DOPAMINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANHEDONIA; ARTICLE; ATTENTIONAL BIAS; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GRIP STRENGTH; HUMAN; IMPLICIT MEMORY; INFLAMMATION; INSULA; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REINFORCEMENT; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WORKING MEMORY; BRAIN; METABOLISM; PSYCHOLOGY;

BRAIN; DECISION MAKING; DEPRESSION; DEPRESSIVE DISORDER; DOPAMINE; HUMANS; INFLAMMATION; MOTIVATION; NEURONAL PLASTICITY; REINFORCEMENT (PSYCHOLOGY);

EID: 84975859239     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2015_400     Document Type: Article

References (124)

1. Agren H, Reibring L (1994) PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27(1): 2-6.
2. Amsterdam JD, Newberg AB (2007) A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology 55(3-4): 167-170.
3. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P-F, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475(7354): 91-95.
4. Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64(2): 238-258.
5. Barch DM, Dowd EC (2010) Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull 36(5): 919-934.
6. Bardgett ME, Depenbrock M, Downs N, Points M, Green L (2009) Dopamine modulates effort-based decision making in rats. Behav Neurosci 123(2): 242-251.
7. Beierholm U, Guitart-Masip M, Economides M, Chowdhury R, Düzel E, Dolan R, Dayan P (2013) Dopamine modulates reward-related vigor. Neuropsychopharmacology 38: 1495-1503.
8. Berridge KC, Kringelbach ML (2008) Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199(3): 457-480.
9. Blume J, Douglas SD, Evans DL (2011) Immune suppression and immune activation in depression. Brain Behav Immun 25(2): 221-229.
10. Bragulat V, Paillere-Martinot ML, Artiges E, Frouin V, Poline JB, Martinot JL (2007) Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F] fluoro-L-dopa positron emission tomography study with voxel-based analysis. Psychiatry Res 154(2): 115-124.
11. Bus B, Molendijk M, Tendolkar I, Penninx B, Prickaerts J, Elzinga B, Voshaar R (2015) Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time. Mol Psychiatry 20(5): 602-608.
12. Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC (2009) Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology 34(5): 1277-1287.
13. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130(2): 226-238.
14. Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B, Berns GS, Nemeroff CB, Miller AH (2007) Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32(11): 2384-2392.
15. Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, Miller AH (2012) Dopaminergic mechanisms of reduced Basal Ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69 (10): 1044-1053.
16. Capuron L, Ravaud A, Miller AH, Dantzer R (2004) Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 18(3): 205-213.
17. Chana G, Landau S, Beasley C, Everall IP, Cotter D (2003) Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 53(12): 1086-1098.
18. Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58(6): 545-553.
19. Couch Y, Anthony DC, Dolgov O, Revischin A, Festoff B, Santos AI, Steinbusch HW, Strekalova T (2013) Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun 29: 136-146.
20. Cousins MS, Salamone JD (1994) Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol Biochem Behav 49(1): 85-91.
21. Croxson PL, Walton ME, O'Reilly JX, Behrens TE, Rushworth MF (2009) Effort-based cost-benefit valuation and the human brain. J Neurosci 29(14): 4531-4541.
22. D'Ardenne K, Nystrom LE, Cohen JD (2008) BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 5867(319): 1264-1267.
23. D'Haenen HA, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35(2): 128-132.
24. Dantzer R, Meagher MW, Cleeland CS (2012) Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol 9(7): 414-426.
25. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8): 793-802.
26. Dickens C, Creed F (2001) The burden of depression in patients with rheumatoid arthritis. Rheumatology 40(12): 1327-1330.
27. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5): 446-457.
28. Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338(6103): 68-72.
29. Dwivedi Y, Rizavi HS, Conley R, Pandey G (2005) ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11(1): 86-98.
30. Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010) Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68(8): 748-754.
31. Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM, Kalin NH, Ratti E, Nemeroff CB, Miller AH (2007) Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 62(11): 1324-1333.
32. Felger JC, Miller AH (2014) Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol.
33. Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL (2013) Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38(11): 2179-2187.
34. Floresco SB (2015) The nucleus accumbens: an interface between cognition, emotion, and action. Annu Rev Psychol 66: 25-52.
35. Foussias G, Remington G (2008) Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull 36(2): 359-369.
36. Frank MJ, O'Reilly RC (2006) A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120(3): 497.
37. Frank MJ, Seeberger LC, O'Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306(5703): 1940-1943.
38. Gershon AA, Vishne T, Grunhaus L (2007) Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 61(2): 145-153.
39. Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA (2008) Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull 34(5): 835-847.
40. Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35(1): 4-26.
41. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66(5): 407-414.
42. Hart AS, Rutledge RB, Glimcher PW, Phillips PEM (2014) Phasic dopamine release in the rat nucleus accumbens symmetrically encodes a reward prediction error term. J Neurosci 34 (3): 698-704.
43. Hartmann MN, Hager OM, Tobler PN, Kaiser S (2013) Parabolic discounting of monetary rewards by physical effort. Behav Process 100: 192-196.
44. Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Nagren K, Salminen JK, Hietala J (2008) Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology 197(4): 581-590.
45. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2): 171-186.
46. Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, Zarate CA Jr (2011) Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 35(4): 1155-1159.
47. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167(7): 748-751.
48. Insel TR, Cuthbert BN (2015) Brain disorders? Precisely. Science 348(6234): 499-500.
49. Kempermann G, Kronenberg G (2003) Depressed new neurons?, Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54(5): 499-503.
50. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S, Williams SC (2011) Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 68(7): 675-690.
51. Klein DF (1974) Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry 31(4): 447-454.
52. Klein DN (1987) Depression and Anhedonia. Anhedonia Affect Deficit States 31: 1-14.
53. Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA (2002) Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 52(7): 740-748.
54. Klimke A, Larisch R, Janz A, Vosberg H, Muller-Gartner HW, Gaebel W (1999) Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90(2): 91-101.
55. Kravitz AV, Tye LD, Kreitzer AC (2012) Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 15(6): 816-818.
56. Kumar P, Waiter G, Ahearn T, Milders M, Reid I, Steele JD (2008) Abnormal temporal difference reward-learning signals in major depression. Brain 131(Pt 8): 2084-2093.
57. Kurniawan IT, Seymour B, Talmi D, Yoshida W, Chater N, Dolan RJ (2010) Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J Neurophysiol 104 (1): 313-321.
58. Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144 (3): 282-285.
59. Lotrich FE, Albusaysi S, Ferrell RE (2013) Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology 38(6): 985-995.
60. Mac Queen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT (2003) Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci 100(3): 1387-1392.
61. Martinot M, Bragulat V, Artiges E, Dolle F, Hinnen F, Jouvent R, Martinot J (2001) Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 158(2): 314-316.
62. McGuire JT, Botvinick MM (2010) Prefrontal cortex, cognitive control, and the registration of decision costs. Proc Natl Acad Sci USA 107(17): 7922-7926.
63. Meehl PE (1975) Hedonic capacity: some conjectures. Bull Menninger Clin 39(4): 295-307.
64. Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH (2001) Lower dopamine transporter binding potential in striatum during depression. NeuroReport 12(18): 4121-4125.
65. Miller AH, Maletic V, Raison CL (2009a) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9): 732-741.
66. Miller AH, Maletic V, Raison CL (2009b) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9): 732-741.
67. Molendijk M, Spinhoven P, Polak M, Bus B, Penninx B, Elzinga B (2014) Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N= 9484). Mol Psychiatry 19(7): 791-800.
68. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651): 1760-1765.
69. Monkul E, Hatch JP, Nicoletti MA, Spence S, Brambilla P, Lacerda AL, Sassi RB, Mallinger A, Keshavan M, Soares JC (2006) Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry 12(4): 360-366.
70. Monteggia LM, Zarate C (2015) Antidepressant actions of ketamine: from molecular mechanisms to clinical practice. Curr Opin Neurobiol 30: 139-143.
71. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ (2013a) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170(10): 1134-1142.
72. Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV (2013b) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74 (4): 250-256.
73. Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Mueller CE, Correa M, Salamone JD (2013) Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task. Psychopharmacology 1-10.
74. Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M, Cooper TB, Van Heertum R, Mann JJ, Laruelle M (2001) Dopamine D (2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 50(5): 313-322.
75. Pessiglione M, Schmidt L, Draganski B, Kalisch R, Lau H, Dolan RJ, Frith CD (2007) How the brain translates money into force: a neuroimaging study of subliminal motivation. Science 316 (5826): 904-906.
76. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442(7106): 1042-1045.
77. Pincus T, Griffith J, Pearce S, Isenberg D (1996) Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 35(9): 879-883.
78. Pittenger C, Duman RS (2007) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33(1): 88-109.
79. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M (2009) Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 166 (6): 702-710.
80. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M (2008) Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 43 (1): 76-87.
81. Prevost C, Pessiglione M, Metereau E, Clery-Melin ML, Dreher JC (2010) Separate valuation subsystems for delay and effort decision costs. J Neurosci 30(42): 14080-14090.
82. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5): 453-462.
83. Rahmim A, Zaidi H (2008) PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun 29(3): 193-207.
84. Raison CL, Miller AH (2011) Is depression an inflammatory disorder? Current Psychiatry Reports 13(6): 467-475.
85. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression. JAMA Psychiatry 70(1): 31-41.
86. Reynolds JN, Hyland BI, Wickens JR (2001) A cellular mechanism of reward-related learning. Nature 413(6851): 67-70.
87. Ribot T (1896) La psychologie des sentiment (The psychology of feelings). Felix Alcan, Paris.
88. Rushworth MF, Noonan MP, Boorman ED, Walton ME, Behrens TE (2011) Frontal cortex and reward-guided learning and decision-making. Neuron 70(6): 1054-1069.
89. Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191(3): 461-482.
90. Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 65(2): 221-229.
91. Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147(2-3): 243-248.
92. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010) The immunoregulatory role of dopamine: an update. Brain Behav Immun 24(4): 525-528.
93. Schmaal L, Veltman DJ, van Erp TG, Sämann P, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, Hofman A, Niessen W (2015) Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Molecular Psychiatry.
94. Schmidt L, Lebreton M, Clery-Melin ML, Daunizeau J, Pessiglione M (2012) Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol 10(2): e1001266.
95. Schultz W (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30: 259-288.
96. Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP (1997) Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 27(6): 1247-1256.
97. Sharot T, Shiner T, Brown AC, Fan J, Dolan RJ (2009) Dopamine enhances expectation of pleasure in humans. Curr Biol 19(24): 2077-2080.
98. Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19(12): 5034-5043.
99. Shelton RC, Tomarken AJ (2001) Can recovery from depression be achieved? Psychiatr Serv 52 (11): 1469-1478.
100. Sherdell L, Waugh CE, Gotlib IH (2011) Anticipatory pleasure predicts motivation for reward in major depression. J Abnorm Psychol.
101. Simon NW, Beas BS, Montgomery KS, Haberman RP, Bizon JL, Setlow B (2013) Prefrontal cortical-striatal dopamine receptor mRNA expression predicts distinct forms of impulsivity. Eur J Neurosci 37: 1779-1788.
102. Strauss GP, Gold JM (2012) A new perspective on anhedonia in Schizophrenia. Am J Psychiatry.
103. Sutton RS, Barto AG (1998) Reinforcement learning: an introduction. MIT Press, Cambridge.
104. Thorne R, Hanson L, Ross T, Tung D, Frey Ii W (2008) Delivery of interferon-β to the monkey nervous system following intranasal administration. Neuroscience 152(3): 785-797.
105. Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012a) Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121(3): 553.
106. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH (2012b) Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci 32(18): 6170-6176.
107. Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH (2009) Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS ONE 4(8): e6598.
108. Treadway MT, Pizzagalli DA (2014) Imaging the pathophysiology of major depressive disorder-from localist models to circuit-based analysis. Biol Mood Anxiety Disord 4(5).
109. Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35(3): 537-555.
110. Treadway MT, Zald DH (2013) Parsing anhedonia translational models of reward-processing deficits in psychopathology. Curr Dir Psychol Sci 22(3): 244-249.
111. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L, Deisseroth K (2009) Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324 (5930): 1080-1084.
112. Vichaya EG, Hunt SC, Dantzer R (2014) Lipopolysaccharide Reduces incentive motivation while boosting preference for high reward in mice. Neuropsychopharmacology.
113. Vrieze E, Ceccarini J, Pizzagalli DA, Bormans G, Vandenbulcke M, Demyttenaere K, Van Laere K, Claes S (2011) Measuring extrastriatal dopamine release during a reward learning task. Hum Brain Mapp.
114. Vrieze E, Pizzagalli DA, Demyttenaere K, Hompes T, Sienaert P, de Boer P, Schmidt M, Claes S (2013) Reduced reward learning predicts outcome in major depressive disorder. Biol Psychiatry.
115. Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H (2011) Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci 31(46): 16597-16602.
116. Westbrook A, Kester D, Braver TS (2013) What is the subjective cost of cognitive effort? Load, trait, and aging effects revealed by economic preference. PLoS ONE 8(7): e68210.
117. Whitton AE, Treadway MT, Pizzagalli DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28(1): 7-12.
118. Wieland S, Schindler S, Huber C, Köhr G, Oswald MJ, Kelsch W (2015) Phasic dopamine modifies sensory-driven output of striatal neurons through synaptic plasticity. J Neurosci 35 (27): 9946-9956.
119. Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome. Cell 160(1): 62-73.
120. Yang X-H, Huang J, Zhu C-Y, Wang Y-F, Cheung EFC, Chan RCK, Xie G-R (2014) Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients. Psychiatry Res 220(3): 874-882.
121. Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008) Greater availability of dopamine transporters in patients with major depression-a dual-isotope SPECT study. Psychiatry Res 162(3): 230-235.
122. Yoshii A, Constantine-Paton M (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70(5): 304-322.
123. Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA (2012) Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71 (11): 939-946.
124. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8): 856-864.